Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
golidocitinib (DZD4205)
i
Other names:
DZD4205, AZD-4205, AZD 4205, AZD4205
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Dizal Pharma
Drug class:
JAK1 inhibitor
Related drugs:
‹
ruxolitinib (73)
AZD1480 (5)
momelotinib (2)
INCB039110 (1)
tofacitinib (1)
INCB052793 (0)
SHR0302 (0)
ruxolitinib (73)
AZD1480 (5)
momelotinib (2)
INCB039110 (1)
tofacitinib (1)
INCB052793 (0)
SHR0302 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Peripheral T-cell Lymphoma
No biomarker
Peripheral T-cell Lymphoma
DZD4205
Sensitive: B - Late Trials
DZD4205
Sensitive
:
B
DZD4205
Sensitive: B - Late Trials
DZD4205
Sensitive
:
B
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login